Market Overview

NeuroMetrix Partners with Omron Medical Devices to Distribute NC-stat DPNCheck in China

NeuroMetrix (Nasdaq: NURO)
announced that it had entered into an agreement with Omron Medical
Devices, a subsidiary of Omron Healthcare China, to be the exclusive
distributor for NC-stat® DPNCheck® in China.
Earlier this year NeuroMetrix and Omron Healthcare Co. Ltd. announced a
partnership for the exclusive distribution of NC-stat DPNCheck in Japan.

NC-stat DPNCheck is a rapid, accurate and quantitative point-of-care
test for early detection of diabetic peripheral neuropathy (DPN), which
affects over half of people with diabetes. DPN causes significant
morbidity including pain, increased risk of falling in the elderly, and

See full press release

Posted-In: News Guidance Contracts Buybacks Management Global

 

Most Popular

Related Articles (NURO)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free